|
Issue |
Title |
|
Vol 2, No 3 (2024) |
The regulatory clinical trial has commenced for “MediReg”®, an original domestically developed biologic drug based on the secretome of human mesenchymal stromal cells |
Abstract
PDF (Rus)
|
Anastasia Yu. Efimenko |
|
Vol 2, No 2 (2024) |
On holding of the VI National Congress on Regenerative Medicine (November 13-15, 2024, St. Petersburg) |
Abstract
PDF (Rus)
|
V. А. Тkachuk |
|
Vol 2, No 1 (2024) |
Development program of the scientific journal “Tissue and organ regeneration” |
Abstract
PDF (Rus)
|
P. I. Makarevich, E. V. Tarasova, A. Yu. Еfimenko, Zh. A. Аkopyan, V. A. Тkachuk |
|
Vol 1, No 2 (2023) |
Editorial |
Abstract
PDF (Rus)
|
P. I. Makarevich |
|
Vol 1, No 1 (2023) |
Message from the Editor-in-Chief |
Abstract
PDF (Rus)
|
V. A. Tkachuk |
|
1 - 5 of 5 Items |
|